These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26486597)

  • 1. Evaluating the Use of the Case Mix Index for Risk Adjustment of Healthcare-Associated Infection Data: An Illustration using Clostridium difficile Infection Data from the National Healthcare Safety Network.
    Thompson ND; Edwards JR; Dudeck MA; Fridkin SK; Magill SS
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):19-25. PubMed ID: 26486597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
    Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network's laboratory-identified event reporting module versus clinical infection surveillance.
    Gase KA; Haley VB; Xiong K; Van Antwerpen C; Stricof RL
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):284-90. PubMed ID: 23388363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying sources of bias in National Healthcare Safety Network laboratory-identified Clostridium difficile infection rates.
    Haley VB; DiRienzo AG; Lutterloh EC; Stricof RL
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):1-7. PubMed ID: 24334790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates.
    Alrawashdeh M; Rhee C; Hsu H; Wang R; Horan K; Lee GM
    JAMA Netw Open; 2021 Oct; 4(10):e2132114. PubMed ID: 34714336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overreporting healthcare-associated C. difficile: A comparison of NHSN LabID with clinical surveillance definitions in the era of molecular testing.
    Albert K; Ross B; Calfee DP; Simon MS
    Am J Infect Control; 2018 Sep; 46(9):998-1002. PubMed ID: 29655671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronically Available Comorbid Conditions for Risk Prediction of Healthcare-Associated Clostridium difficile Infection.
    Harris AD; Sbarra AN; Leekha S; Jackson SS; Johnson JK; Pineles L; Thom KA
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):297-301. PubMed ID: 29397800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.
    Rohra S; Poojary A; Patil P; John S; Michael R; Johnson S; Pardeshi P
    Indian J Med Microbiol; 2023; 46():100425. PubMed ID: 37945118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.
    Miller AC; Polgreen LA; Cavanaugh JE; Polgreen PM
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):404-10. PubMed ID: 26858126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
    Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
    Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006.
    Campbell RJ; Giljahn L; Machesky K; Cibulskas-White K; Lane LM; Porter K; Paulson JO; Smith FW; McDonald LC
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):526-33. PubMed ID: 19419272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of 2018 Changes in National Healthcare Safety Network Surveillance for Clostridium difficile Laboratory-Identified Event Reporting.
    Marra AR; Edmond MB; Ford BA; Herwaldt LA; Algwizani AR; Diekema DJ
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):886-888. PubMed ID: 29708091
    [No Abstract]   [Full Text] [Related]  

  • 14. Clostridium difficile infections in Veterans Health Administration acute care facilities.
    Evans ME; Simbartl LA; Kralovic SM; Jain R; Roselle GA
    Infect Control Hosp Epidemiol; 2014 Aug; 35(8):1037-42. PubMed ID: 25026621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for the current National Healthcare Safety Network (NHSN) >3 days after admission definition of laboratory-identified, healthcare-facility-onset,
    Puri S; Hughes HY; McCrackin MD; Williford R; Gebregziabher M; Salgado CD; Curry SR
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):467-468. PubMed ID: 31973777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics.
    Kelly SG; Yarrington M; Zembower TR; Sutton SH; Silkaitis C; Postelnick M; Mikolajczak A; Bolon MK
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1395-1400. PubMed ID: 27666285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection.
    Durkin MJ; Baker AW; Dicks KV; Lewis SS; Chen LF; Anderson DJ; Sexton DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2015 Feb; 36(2):125-31. PubMed ID: 25632994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: a cause for concern.
    Tan XQ; Verrall AJ; Jureen R; Riley TV; Collins DA; Lin RT; Balm MN; Chan D; Tambyah PA
    Int J Antimicrob Agents; 2014 Jan; 43(1):47-51. PubMed ID: 24290727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile Infections in Veterans Health Administration Long-Term Care Facilities.
    Reeves JS; Evans ME; Simbartl LA; Kralovic SM; Kelly AA; Jain R; Roselle GA
    Infect Control Hosp Epidemiol; 2016 Mar; 37(3):295-300. PubMed ID: 26686361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can National Healthcare-Associated Infections (HAIs) Data Differentiate Hospitals in the United States?
    Masnick M; Morgan DJ; Sorkin JD; Macek MD; Brown JP; Rheingans P; Harris AD
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1167-1171. PubMed ID: 28903802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.